Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination

NCT01830283 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01830283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2013
Completion date
April 30, 2018
Enrollment
50,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

varicella